Orexo (2 drugs' world rights) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Orexo (2 drugs' world rights) General Information

Description

Commercialization rights of Edluar and OX-NLA. It consists of the world wide distribution and marketing rights of the drugs Edluar and OX-NLA.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • P.O. Box 303
  • 751 05 Uppsala
  • Sweden
Primary Industry
Buildings and Property
Other Industries
Other Business Products and Services
Distributors (Healthcare)
Acquirer
Meda
Corporate Office
  • P.O. Box 303
  • 751 05 Uppsala
  • Sweden

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Orexo (2 drugs' world rights) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Orexo (2 drugs' world rights)‘s full profile, request access.

Request a free trial

Orexo (2 drugs' world rights) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Orexo (2 drugs' world rights)‘s full profile, request access.

Request a free trial

Orexo (2 drugs' world rights) FAQs

  • Where is Orexo (2 drugs' world rights) headquartered?

    Orexo (2 drugs' world rights) is headquartered in Uppsala, Sweden.

  • What industry is Orexo (2 drugs' world rights) in?

    Orexo (2 drugs' world rights)’s primary industry is Buildings and Property.

  • Is Orexo (2 drugs' world rights) a private or public company?

    Orexo (2 drugs' world rights) is a Private company.

  • What is Orexo (2 drugs' world rights)’s current revenue?

    The current revenue for Orexo (2 drugs' world rights) is 000000.

  • Who are Orexo (2 drugs' world rights)’s investors?

    Orexo has invested in Orexo (2 drugs' world rights).

  • When was Orexo (2 drugs' world rights) acquired?

    Orexo (2 drugs' world rights) was acquired on 14-Apr-2008.

  • Who acquired Orexo (2 drugs' world rights)?

    Orexo (2 drugs' world rights) was acquired by Meda.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »